EN ID
0
Online sekarang

Sigma Peptides Retatrutide (20mg) + Tirzepatide (40mg) 60mg

FOR SCIENTIFIC RESEARCH AND LABORATORY USE ONLY

Sigma Peptides Retatrutide (20mg) + Tirzepatide (40mg) 60mg — a triple agonist paired with a dual GIP/GLP-1 agonist. Purity of ≥99.4% with LC-MS identity verification. Includes BAC water, a syringe and alcohol pads.

Rp 2.850.000

This combination vial holds Retatrutide (a triple GLP-1/GIP/glucagon agonist) alongside Tirzepatide (a dual GIP/GLP-1 agonist) in a single preparation. The paired format is common in comparative incretin-pathway research, where both compounds are examined against the same metabolic endpoints. The 20mg size is available to match the volume your research requires.

Every batch is tested by an independent laboratory: purity ≥99.4%, identity confirmed by LC-MS, and endotoxin below 0.5 EU/mg.

In lyophilised powder form, store at 2–8 °C protected from light. After reconstitution with BAC water, maintain at 2–8 °C. Available for delivery throughout Indonesia, packaged to preserve product condition.

For in-vitro and laboratory research use only.